Cargando…
Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC
BACKGROUND: Epidermal Growth Factor Receptor (EGFR) targeting therapies are currently of great relevance for the treatment of lung cancer. For this reason, in addition to mutational analysis immunohistochemistry (IHC) of EGFR in lung cancer has been discussed for the decision making of according the...
Autores principales: | Gaber, Rania, Watermann, Iris, Kugler, Christian, Reinmuth, Nils, Huber, Rudolf M, Schnabel, Philipp A, Vollmer, Ekkehard, Reck, Martin, Goldmann, Torsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176848/ https://www.ncbi.nlm.nih.gov/pubmed/25227424 http://dx.doi.org/10.1186/s13000-014-0165-0 |
Ejemplares similares
-
Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?
por: Watermann, I., et al.
Publicado: (2015) -
Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation
por: Hattar, Katja, et al.
Publicado: (2012) -
Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC
por: Wei, Jiacong, et al.
Publicado: (2021) -
Identification of molecular signatures associated with early relapse after complete resection of lung adenocarcinomas
por: Pasternack, Helen, et al.
Publicado: (2021) -
Liquid biopsy uncovers distinct patterns of DNA methylation and copy number changes in NSCLC patients with different EGFR-TKI resistant mutations
por: Nguyen, Hoai-Nghia, et al.
Publicado: (2021)